BMY
43
2
BEN
34
6
MAS
59
3
HCP
54
7
V
56
2
DHI
48
4
PM
66
6
ICE
57
2
K
56
5
EFX
40
4
LRCX
48
6
HRB
56
2
LOW
53
3
BDX
41
3
VRTX
62
10
KEY
34
3
MU
39
5
DG
27
-2
CMI
59
14
CA
16
3
BMY
43
2
BEN
34
6
MAS
59
3
HCP
54
7
V
56
2
DHI
48
4
PM
66
6
ICE
57
2
K
56
5
EFX
40
4
LRCX
48
6
HRB
56
2
LOW
53
3
BDX
41
3
VRTX
62
10
KEY
34
3
MU
39
5
DG
27
-2
CMI
59
14
CA
16
3
Financhill
Back

Alnylam Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
265.13
Seasonality Move:
13.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Alnylam Pharmaceuticals Price Quote

$265.13
-0.16 (-1.78%)
(Updated: November 6, 2024 at 4:58 AM ET)

Alnylam Pharmaceuticals Key Stats

Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell
Day range:
$264.23 - $268.89
52-week range:
$141.98 - $304.39
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
16.05
P/B ratio:
1057.59%
Volume:
940.3K
Avg. volume:
784.9K
1-year change:
58.52%
Market cap:
$34.2B
Revenue:
$1.8B
EPS:
$-2.62

How Much Does Alnylam Pharmaceuticals Make?

Is Alnylam Pharmaceuticals Growing As A Company?

Alnylam Pharmaceuticals Stock Price Performance

What Is Alnylam Pharmaceuticals 52-Week High & Low?

Alnylam Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Alnylam Pharmaceuticals?

Is Alnylam Pharmaceuticals Cash Flow Positive?

  • What Is ALNY Cash Flow From Operations?
    Cash flow from operations (TTM) is $56.6M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $302.4M
  • What Is Alnylam Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$304.6M

Alnylam Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ALNY return on invested capital is -36.66%
  • What Is Alnylam Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -8.43%
  • What Is ALNY Return On Equity?
    ROE is a measure of profitability and is 0%

Alnylam Pharmaceuticals Earnings Date & Stock Price

Alnylam Pharmaceuticals Competitors

Alnylam Pharmaceuticals Dividend Yield

Alnylam Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.71%
Revenue: -33.26% -4.95%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 8
Sell Recommendations: 0
Price Target: 301.58
Upside from Last Price: 13.68%

Major Shareholders

  • How many ALNY shares are owned by institutional investors?
    247.2M ALNY shares are owned by institutional investors
  • How many ALNY shares are owned by insiders?
    534.6K ALNY shares are owned by insiders